AJP - Regu AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 264: R917-R923, 1993;
0363-6119/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scheuer, D. A.
Right arrow Articles by Perrone, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheuer, D. A.
Right arrow Articles by Perrone, M. H.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 264, Issue 5 917-R923, Copyright © 1993 by American Physiological Society


ARTICLES

Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin

D. A. Scheuer and M. H. Perrone
Rhone Poulenc Rorer Central Research, Collegeville, Pennsylvania 19426-0107.

Angiotensin (ANG) can produce a biphasic arterial pressure response, i.e., an increase followed by a decrease. Because ANG type 1 (AT1) receptors mediate the pressor response to ANG, we hypothesized that the opposing depressor action is mediated by the ANG type 2 (AT2) receptors. In thiobutabarbital (Inactin)-anesthetized rats bolus injections of angiotensin III (ANG III; 100, 300, and 1,000 ng/kg iv) produced peak increases in MAP at 20 s of 13.4 +/- 1.4, 20.1 +/- 2, and 27.5 +/- 2.8 mmHg and maximum decreases in pressure at 120 s of -6.3 +/- 1.5, -6.8 +/- 2.2, and -11.4 +/- 4.9 mmHg. During blockade of the AT1 receptors with DuP 753 (losartan, 10 mg/kg) the increases in MAP were eliminated (P < 0.01), whereas the depressor responses (-24.7 +/- 8, -32.8 +/- 9.3, and -42.0 +/- 10.0 mmHg) were significantly (P < 0.05) larger. In separate groups of rats, combined blockade of both AT1 and AT2 receptors eliminated all changes in MAP in response to ANG III, whereas blockade of AT2 receptors alone enhanced the pressor response to ANG III. During AT1 receptor blockade angiotensin II also caused consistent decreases in pressure, which were inhibited during combined blockade of AT1 and AT2 receptors. Therefore, we have demonstrated that the AT2 receptors mediate a depressor response to ANG.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. McMullen and S. C. Langley-Evans
Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R85 - R90.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Rugale, S. Delbosc, J.-P. Cristol, A. Mimran, and B. Jover
Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1744 - H1750.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. F. de Godoy and A. M. de Oliveira
Cross-Talk Between AT1 and AT2 Angiotensin Receptors in Rat Anococcygeus Smooth Muscle
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
F. Ryckwaert, P. Colson, E. Andre, P.-F. Perrigault, G. Guillon, and C. Barberis
Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig
Br. J. Anaesth., October 1, 2002; 89(4): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
O. Lorenzo, M. Ruiz-Ortega, Y. Suzuki, M. Ruperez, V. Esteban, T. Sugaya, and J. Egido
Angiotensin III Activates Nuclear Transcription Factor-{kappa}B in Cultured Mesangial Cells Mainly via AT2 Receptors: Studies with AT1 Receptor-Knockout Mice
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1162 - 1171.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy
Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats
Hypertension, December 1, 2001; 38(6): 1272 - 1277.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Henrion, N. Kubis, and B. I. Levy
Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation
Hypertension, November 1, 2001; 38(5): 1150 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. S. Weber and J. H. Lombard
Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2196 - H2202.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M.-H. Liu, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He
Inhibition of vasoconstriction by angiotensin receptor antagonist GR117289C in arterial grafts
Ann. Thorac. Surg., December 1, 2000; 70(6): 2064 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kawai, S. Y. Stevens, and C.-S. Liang
Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. P. Rowe and B. Dixon
Angiotensin III Depressor Action in the Conscious Rabbit Is Blocked by Losartan but not PD 123319
Hypertension, January 1, 2000; 35(1): 130 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X. RUAN, M. I. OLIVERIO, T. M. COFFMAN, and W. J. ARENDSHORST
Renal Vascular Reactivity in Mice: AngII-Induced Vasoconstriction inAT1A Receptor Null Mice
J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2620 - 2630.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. J. Bivalacqua, A. Dalal, H. C. Champion, and P. J. Kadowitz
Role of AT1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E838 - E847.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. N. Barber, D. B. Sampey, and R. E. Widdop
AT2 Receptor Stimulation Enhances Antihypertensive Effect of AT1 Receptor Antagonist in Hypertensive Rats
Hypertension, November 1, 1999; 34(5): 1112 - 1116.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Inoue, Z. Mi, D. G. Gillespie, R. K. Dubey, and E. K. Jackson
Angiotensin Receptor Subtype 1 Mediates Angiotensin II Enhancement of Isoproterenol-Induced Cyclic AMP Production in Preglomerular Microvascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1229 - 1234.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
N. HILL-KAPTURCZAK, M. H. KAPTURCZAK, E. R. BLOCK, J. M. PATEL, T. MALINSKI, K. M. MADSEN, and C. C. TISHER
Angiotensin II-Stimulated Nitric Oxide Release from Porcine Pulmonary Endothelium Is Mediated by Angiotensin IV
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 481 - 491.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Tamura, Y. Wanaka, E. J. Landon, and T. Inagami
Intracellular Sodium Modulates the Expression of Angiotensin II Subtype 2 Receptor in PC12W Cells
Hypertension, February 1, 1999; 33(2): 626 - 632.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz, D. Endemann, G. He, J.-S. Li, and E. L. Schiffrin
Role of AT2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR
Hypertension, January 1, 1999; 33(1): 366 - 372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. H. Nora, D. H. Munzenmaier, F. M. Hansen-Smith, J. H. Lombard, and A. S. Greene
Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle
Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1395 - H1403.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Gorelik, L. A. Carbini, and A. G. Scicli
Angiotensin 1-7 Induces Bradykinin-Mediated Relaxation in Porcine Coronary Artery
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 403 - 410.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Cervenka, C.-T. Wang, and L. G. Navar
Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats
Am J Physiol Renal Physiol, May 1, 1998; 274(5): F940 - F945.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. C. Champion, M. A. Czapla, and P. J. Kadowitz
Responses to angiotensin peptides are mediated by AT1 receptors in the rat
Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E115 - E123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. A. Garrison, H. C. Champion, and P. J. Kadowitz
[Pro11,D-Ala12]angiotensin I has rapid onset vasoconstrictor activity in the cat
Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1059 - E1064.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Broughton Pipkin and P. N. Baker
Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women
Hypertension, November 1, 1997; 30(5): 1247 - 1252.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. C. Champion and P. J. Kadowitz
Analysis of the Effects of Candesartan in the Mesenteric Vascular Bed of the Cat
Hypertension, November 1, 1997; 30(5): 1260 - 1266.
[Abstract] [Full Text]


Home page
CirculationHome page
W. R. Huckle, M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. Fujita, I. I. Stabilito, D. Kim, D. L. Ondeyka, et al.
Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis
Circulation, March 1, 1996; 93(5): 1009 - 1019.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. H. Munzenmaier and A. S. Greene
Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure
Hypertension, March 1, 1996; 27(3): 760 - 765.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
T. Ichiki, Y. Kambayashi, and T. Inagami
Multiple Growth Factors Modulate mRNA Expression of Angiotensin II Type-2 Receptor in R3T3 Cells
Circ. Res., December 1, 1995; 77(6): 1070 - 1076.
[Abstract] [Full Text]


Home page
HypertensionHome page
V. Cachofeiro, R. Maeso, E. Rodrigo, J. Navarro, L. M. Ruilope, and V. Lahera
Nitric Oxide and Prostaglandins in the Prolonged Effects of Losartan and Ramipril in Hypertension
Hypertension, August 1, 1995; 26(2): 236 - 243.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online